Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis
‐‐
Devis Benfaremo +7 more
wiley +1 more source
Weil's disease: rapid recovery following corticosteroid treatment: a case report. [PDF]
Şahin AM, Atçı-Koç İ, Çetin S.
europepmc +1 more source
Prolotherapy in the Treatment of Knee Osteoarthritis: How to Perform
Abstract The conservative treatment of knee osteoarthritis is a challenge; since it has no cure, many patients do not want or cannot undergo surgical procedures. Among the various options, we have injectable therapies, especially the so‐called “regenerative,” such as the use of hyaluronic acid, orthobiologicals, and prolotherapy. In the latter, its use
José L. Rocha de Faria +13 more
wiley +1 more source
Background: Acute lung injury or acute respiratory distress syndrome (ARDS) is one of the most common complications of non-fatal drowning. Although respiratory societies’ guidelines endorse the role of systemic corticosteroids in ARDS, the evidence for ...
Eric Daniel Tenda +7 more
doaj
Corticosteroid-resistant Terbinafine-induced Acute Generalized Exanthematous Pustulosis: Therapeutic Challenges and Clinical Infection Overlap. [PDF]
Svizzero A +6 more
europepmc +1 more source
Step‐by‐Step Technique for Platelet‐Rich Plasma Gel Preparation and Use in Knee Osteoarthritis
Abstract Knee osteoarthritis (OA) remains a leading cause of pain and disability worldwide, and current injectable options such as corticosteroids and hyaluronic acid often provide limited or short‐term benefits. Orthobiologic therapies, particularly platelet‐rich plasma (PRP), have gained attention for their regenerative and anti‐inflammatory ...
Diego Ariel de Lima +6 more
wiley +1 more source
Osteonecrosis of the humeral head under corticosteroid therapy for non-medical reason in a 14-year-old female patient: A case report. [PDF]
Bahha S +9 more
europepmc +1 more source
Navigating adverse immunostimulation: A practical guide for clinical researchers
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort +3 more
wiley +1 more source
ARDS and corticosteroids: beyond COVID-19. [PDF]
Esperatti M, Olmos M, Fuentes N.
europepmc +1 more source

